Raphas Co Ltd
214260
Company Profile
Business description
Raphas Co Ltd is engaged in the development of a drug delivery system. The company's products include Acropass, Cosmetics ODM, and Medical Contract Manufacturing Services. Its products are mostly used in biomedical products and all-natural cosmetic materials.
Contact
62, Magokjungang 8-ro 1-gil
Gangseo-gu
Seoul07793
KORT: +82 23923011
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
100
Stocks News & Analysis
stocks
Ask the analyst: Where does GYG stand following its US exit?
All roads lead back home for Guzman Y Gomez.
stocks
Chart of the Week: The long term headwinds facing copper shares
The key factors challenging the bull case for copper demand.
stocks
Australia’s oldest REIT undervalued
This REIT remains undervalued as trophy properties shine through.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,048.30 | 74.60 | 0.83% |
| CAC 40 | 8,508.07 | 33.21 | 0.39% |
| DAX 40 | 25,779.31 | 198.43 | 0.78% |
| Dow JONES (US) | 52,900.07 | 594.83 | 1.14% |
| FTSE 100 | 10,679.03 | 26.16 | 0.25% |
| HKSE | 23,350.03 | 295.00 | 1.28% |
| NASDAQ | 25,832.67 | 207.36 | -0.80% |
| Nikkei 225 | 69,744.07 | 1,010.92 | 1.47% |
| NZX 50 Index | 13,618.42 | 36.23 | 0.27% |
| S&P 500 | 7,483.24 | 0.01 | 0.00% |
| S&P/ASX 200 | 8,844.40 | 75.10 | 0.86% |
| SSE Composite Index | 4,043.64 | 14.74 | 0.37% |